Serotonergic anti-depressants and ethanol withdrawal syndrome: A review

Alcohol and Alcoholism

Volumn 43, Issue 1, 2008, Pages 15-24

  Uzbay, I Tayfun ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; HYPERICUM PERFORATUM EXTRACT; TIANEPTINE; VENLAFAXINE;

AGITATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AUDIOGENIC SEIZURE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HYPERACTIVITY; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEROTONINERGIC SYSTEM; STEREOTYPY; TREMOR; WET DOG SHAKES;

ALCOHOL DRINKING; ANIMALS; ANTIDEPRESSIVE AGENTS; CITALOPRAM; ETHANOL; FLUOXETINE; HUMANS; HYPERICUM; MOTOR ACTIVITY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

CANIS FAMILIARIS; HYPERICUM PERFORATUM; RATTUS; RATTUS NORVEGICUS;

EID: 37749042738     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agm145     Document Type: Review

References (102)

1. Alici, T., Kayir. H., Saglam, E. et al. (2006) Discriminative stimulus properties of tianeptine. Psychopharmacology 183, 446-451.
2. Auquier, P., Robitail, S., Llorca, P. M. et al. (2003) Comparison of escitalopram and citalopram efficacy: A meta-analysis. International Journal of Psychiatry in Clinical Practice 7, 259-268.
3. Bennett, D. A., Phun, L., Polk, J. F. et al. (1998) Neuropharmacology of St John's wort (Hypericum). Annals of Pharmacotherapy 32, 1201-1208.
4. Butterweck, V., Wall, A., Lieflander-Wulf, U. et al. (1997) Effects of total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30 (Suppl. 2), 117-124.
5. Calapai, G., Crupi, A., Firenzuoli, F. et al. (1999) Effects of Hypericum perforatum on levels of 5-hydroxytriptamine, noradrenaline and dopamine in the cortex, diencephalons and brainstem of the rat. Journal of Pharmacy and Pharmacology 51, 723-728.
6. Concas, A., Mascia, M. P., Cuccheddu, T. et al. (1996) Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum. Pharmacology Biochemistry and Behavior 53, 249-255.
7. Contreras, C. M., Rodriguez-Landa, J. F., Gutierrez-Garcia, A. G. et al. (2001) The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat. Journal of Psychopharmacology 15, 231-236.
8. Coskun, I., Uzbay, I. T., Ozturk, N. et al. (2006) Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats. Fundamental & Clinical Pharmacology 20, 481-488.
9. Cott, J. M. (1997) In vivo receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 30 (Suppl. 2), 108-112.
10. Cowen, P. J. (1998) Pharmacological challenge tests and brain serotonergic function in depression during SSRI treatment. In Antidepressant Therapy, Briley, M., Montgomery, S. eds, Martin Dunitz Ltd, London, pp. 175-189.
11. Curzon, G. and Datla, K. P. (1993) Effects of tianeptine on behavioral and neurochemical responses in immobilization stress. European Psychiatry 8 (Suppl. 2), 61S-66S.
12. Daoust, M., Compagnon, P., Legrand, E. et al. (1992) Tianeptine, a specific serotonine uptake enhancer, decreases ethanol intake in rats. Alcohol and Alcoholism 27, 15-17.
13. Detke, M. J., Rickels, M. and Lucki, I. (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121, 66-72.
14. De Vry, J., Maruel, S., Schreiber, R. et al. (1999) Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. European Neuropsychopharmacology 9 461-468.
15. De Witte, P., Pinto, E., Ansseau, M. et al. (2003) Alcohol withdrawal: From animal research to clinical issues. Neuroscience and Biobehavioral Reviews 27, 189-197.
16. Dierick, M. (1997) A review of the efficacy and tolerability of venlafaxine. European Psychiatry 12 (Suppl. 4), 307s-313s.
17. Favre, J. D., Guelfi-Sozzi, C., Delalleau, B. et al. (1997) Tianeptine and alcohol dependence. European Neuropsychopharmacology 7 (Suppl. 3), S347-S351.
18. Ferreira, L. and Soares-DaSilva, P. (1991) 5-hydroxytryptamine and alcoholism. Human Psychopharmacology 6 (Suppl. 1), S21-S24.
19. Fichter, M. M., Narrow, W. E., Roper, M. T. et al. (1996) Prevalance of mental illness in Germany and the United States: comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. Journal of Nervous and Mental Disease 184, 598-606.
20. File, S. E., Andrews, N. and Al-Farhan, M. (1993) Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: Effects of tianeptine. Alcohol and Alcoholism 28, 281-286.
21. Garattini, S., Giacolone, E. and Valzelli, L. (1967) Isolation, agressiveness and brain 5-hydroxytriptamine turnover. Journal of Pharmacy and Pharmacology 19, 338-339.
22. Garzon, J. and del Rio, J. (1981) Hypersensitivity induced in rats by long tern isolation: Further studies on a new animal model for the detection of antidepressants. European Journal of Pharmacology 74, 287-294.
23. Gatch, M. B., Wallis, C. J. and Lal, H. (2000) Effects of ritanserin on ethanol withdrawal-induced anxiety in rats. Alcohol 21, 11-17.
24. Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L. et al. (2000) Efficacy of ventafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6 month randomized controlled trial. JAMA-Journal of the American Medical Association 283, 3082-3088.
25. Gorman, J. M. (2003) Treating generalized anxiety disorders. Journal of Clinical Psychiatry 64 (Suppl. 2), 24-29,
26. Greeson, J. M., Sanford, B. and Monti, D. A. (2001) St. John's wort ( Hypericum perforatum): A review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153 402-414.
27. Guelfi, J. D. (1992) Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview. British Journal of Psychiatry 160 (Suppl. 15), 72-75.
28. Hardy, P. A., Chen, W. and Wilce, P. A. (1999) Chronic-ethanol exposure and withdrawal influence NMDA receptor subunit and splice variant mRNA expression in the rat cerebral cortex. Brain Research 819, 33-39.
29. Holliday, S. M. and Benfield, P. (1995) Venlafaxine: A review of its pharmacology and therapeutic potential in depression. Drugs 49 280-294.
30. Janiri, L., Gobbi, G., Marinelli, P. et al. (1996) Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. International Clinical Psychopharmacology 11, 109-117.
31. Kaplan, G. B., Bharmal, N. H., Leite-Morris, K. A. et al. (1999) Role of adenosine Al and A2A receptors in the alcohol withdrawal syndrome. Alcohol 19, 157-162.
32. Kasper, S. and Dienel, A. (2002) Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 164, 301-308.
33. Kiianmaa, K., Stenius, K. and Sinclair, J. D. (1991) Determinants of alcohol preference in the AA and ANA rat lines selected for differential ethancl intake. Alcohol and Alcoholism 26, 115-120.
34. Kole, M. H., Swan, L. and Fuchs, E. (2002) The antidepressant tianeptine persistently modulates glutarnate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. European Journal of Neuroscience 16, 807-816.
35. LeMarquand, D., Pihl, R. O. and Benkelfat, C. (1994) Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies. Biological Psychiatry 36, 395-421.
36. Leonard, B. E. (1998) Animal models of depression. In Antidepressant Therapy, Briley, M., Montgomery, S. eds, Martin Dunitz Ltd, London, pp. 87-109.
37. Lepine, J. P., Gastpar, M., Mendelwicz, J. et al. (1997) The prevalence of depression in the community; the first pan-European study DEPRES (Depression Research in European Society). International Clinical Psychopharmacology 12, 19-29.
38. Lepola, U. M., Loft, H. and Reines, E. H. (2003) Escitalopram (10-20 mg/ day) is effective and well tolerated in a placebo-controlled study in depression in primary care. International Clinical Psychopharmacology 18, 211-217.
39. Liljequist, S. (1991) The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. European Journal of Pharmacology 192, 197-198.
40. Linde, K., Ramirez, G., Mulrow, C. D. et al. (1996) St John's wort for depression - an overview and meta-analysis of randomized clinical tirals. British Medical Journal 313, 253-258.
41. Linnoila, M., Mefford, I., Nutt, D. et al. (1987) NIH conference. Alcohol withdrawal and noradrenergic function. Annals of Internal Medicine 107, 875-889.
42. Lǒo, H., Saiz-Ruiz, J., Costa e Silva, J. A. et al. (1999) Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Journal of Affective Disorders 56, 109-118.
43. Lu, L., Wen-Juan, S., Yue, W. et al. (2001) Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor. Life Sciences 69, 37-46.
44. Luo, L. and Tan, R.-X. (2001) Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacologica Sinica 22, 865-870.
45. Majchrowicz, E. (1975) Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 43, 1993-1996.
46. Malka, R., Loo, H., Ganry, H. et al. (1992) Long-term administration of tianeptine in depressed patients after alcohol withdrawal. British Journal of Psychiatry 160 (Suppl. 15), 66-71.
47. McBride, W. J., Murphy, J. M., Gatto, G. J. et al. (1991) Serotonin and dopamine systems regulating alcohol intake. Alcohol and Alcoholism (Suppl. 1), 411-416.
48. McEwen, B. S. and Magarinos, A. M. (2001) Stress and hippocampal plasticity: Implications for the pathophysiology of affective disorders. Human Psychopharmacology 16 (Suppl. 1), S7-S19.
49. Melchart, D. (1996) St John's wort for depression - an overview and meta-analysis of randomized clinical trials. British Medical Journal 313, 241-242.
50. Mennini, T., Mocaër, E. and Garattini, S. (1987) Tianepfine, a selective enhancer of serotonin uptake in rat brain. Naunyn-Schmiedeberg's Archieves of Pharmacology 336, 478-482.
51. Miguel-Hidalgo, J. and Rajkowska, G. (2003) Comparison of prefrontal cell pathology between depression and alcohol dependence. Journal of Psychiatric Research 37, 411-420.
52. Miller, N. S. (1995) Pharmacotherapy in alcoholism. Journal of Addictive Diseases 14, 23-46.
53. Mitchel, P. J. and Fletcher, A. (1993) Venlafaxine exhibits preclinical antidepressant activity in the resident-intruder social interaction paradigm. Neuropharmacology 32, 1001-1009.
54. Morriset, R. A., Rezvani, A. H., Overstreet, D. et al. (1990) MK-801 potently inhibits alcohol withdrawal seizures in rats. European Journal of Pharmacology 176, 103-105.
55. Murphy, J. M., McBride, W. J., Lumeng, L. et al. (1987) Contents of monoamines in forebrain regions of alcohol-preferring (P) and - nonpreferring (NP) lines of rats. Pharmacology Biochemistry and Behavior 26, 389-392.
56. Muth, E. A., Haskins, J. T., Moyer, J. A. et al. (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochemical Pharmacology 35, 4493-4497.
57. Myrick, H., Brady, K. T. and Malcolm, R. (2001) New developments in the pharmacotherapy of alcohol dependence. American Journal on Addictions 10 (Suppl.), 3-15.
58. Neary, J. T. and Bu, Y. (1990) Hypericum. LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Research 816 358-363.
59. Ninan, P. T. (2000) Use of venlafaxine in other psychiatric disorders. Depression and Anxiety 12 (Suppl. 1), 90-94. O'Brien, C. P. (1996) Drug addiction and drug abuse. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., Gilman, A. G. eds, McGraw-Hill, New York, pp. 557-575.
60. Overstreet, D. H., Rezvani, A. H. and Janowsky, D. S. (1992) Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biological Psychiatry 31, 919-936.
61. Ozturk, Y. (1997) Testing the antidepressant effects of hypericum species on animal models. Pharmacopsychiatry 30 (Suppl. 2), 125-128.
62. Ozturk, Y., Aydin, S., Beis, R. et al. (1996) Effects of Hypericum perforatum L. and Hypericum calycinum L. Extracts on the central nervous system in mice. Phytomedicine 3, 139-146.
63. Perfumi, M., Ciccocioppo, R., Angeletti, S. et al. (1999) Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol and Alcoholism 34 690-698.
64. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol and Alcoholism 36 199-206.
65. Perfumi,.M., Santoni, M., Ciccocioppo, R. et al. (2002) Blockade of γ-aminobutyric acid receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rat. Alcohol and Alcoholism 37, 540-546.
66. 2 extract on the motivational properties of ethanol in alcohol-preferring rats. Alcohol and Alcoholism 40 291-296.
67. Perovic, S. and Muller, W. E. G. (1995) Pharmacological profile of hypericum extracts. Effect on serotonine uptake by postsynaptic receptors. Arzneimittel-Forschung-Drug Research 45, 145-148.
68. Reagan, L. P., Rosell, D. R., Wood, G. E. et al. (2004) Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: Reversal by tianeptine. Proceedings of the National Academy of Sciences of the United States of America 101, 2184-2197.
69. Rezvani, A. H., Overstreet, D. H. and Janowsky, D. S. (1990) Genetic serotonin deficiency and alcohol preference in the fawn hooded rats. Alcohol and Alcoholism 25, 573-575.
70. Rezvani, A. H., Overstreet, D. H., Yang, Y. et al. (1999) Attenuation of alcohol intake by extract of Hypericum perforatum (St John's Wort) in two different strains of alcohol-preferring rats. Alcohol and Alcoholism 34, 699-705.
71. Romeo, E., Pompili, E., di Michele, F. et al. (2000) Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World Journal of Biological Psychiatry 1, 101-104.
72. Rossetti, Z. and Carboni, S. (1995) Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. European Journal of Pharmacology 283, 177-183.
73. Roy, A., Virkunnen, M. and Linnotia, M. (1987) Reduced central serotonin turnover in subgroup of alcoholics. Biological Psychiatry 11 173-177.
74. Saglam, E., Uzbay, I. T., Kayir, H. et al. (2004) Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundamental & Clinical Pharmacology 18, 693 -698.
75. Saglam, E., Kayir, H., Çelik, T. et al. (2006) Effects of escitalopram on ethanol withdrawal syndrome in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30, 1027-1032.
76. Saiz-Ruiz, J., Montes, J. M., Alvarez, E. et al. (1998) Tianeptine therapy for depression in the elderly. Progress in Neuro-Psychopharmacology & Biological Psychiatry 22, 319-329.
77. Sánchez, C., Bogeso, K. P., Ebert, B. et al. (2004) Escitalopram versus citalopram: The surprising role of the R-enantiomer. Psychopharmacology 174, 163-176.
78. Schuckit, M. A. (2000) Drug and Alcohol Abuse. A Clinical Guide to Diagnosis and Treatment. Kluwer Academic/Plenum Publishers, New York, p. 42.
79. Sellers, E. M., Higgins, G. A. and Sobel, M. B. (1992) 5-HT and alcohol abuse. Trends in Pharmacological Sciences 13, 69-75.
80. Stahl, S. M. (1996) Essential Psychopharmacology. Cambridge University Press, Cambridge, p. 30.
81. Staner, L. and Mendlewicz, J. (1993). Efficacy of tianeptine in the treatment of major depression and depressed bipolar disorders. Illustration of the interest of surveillance of a European multicentre double-blind study in progress: Ganeptine versus placebo and imipramine. European Psychiatry 8 (Suppl. 2), 11S-115S.
82. Stokes, P. E. and Holtz, A. (1997) Fluoxetine tenth anniversary update: the progress continues. Clinical Therapeutics 19, 1135-1250.
83. Tatsumi, M., Groshan, K., Blakely, R. D. et al. (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology 340, 249-258.
84. Thompson, W. L. (1978) Management of alcohol withdrawal syndromes. Advances in Internal Medicine 138, 278-283.
85. Thomas, J. D., Weinert, S. P., Sharif, S. et al. (1997) MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits. Alcoholism-Clinical and Experimental Research 21, 1218-1225.
86. Tsai, G., Gastfriend, D. R. and Coyle, J. T. (1995) The glutamatergic basis of human alcoholism. American Journal of Psychiatry 152 332-340.
87. Uzbay, I. T. and Kayaalp, S. O. (1995) A modified liquid diet of chronic ethanol administration: Validation by ethanol withdrawal syndrome in rats. Pharmacological Research 31, 37-42.
88. Uzbay, I. T. and Oglesby, M. W. (2001) Nitric oxide and substance dependence. Neuroscience and Biobehavioral Reviews 25, 43-52.
89. Uzbay, I. T., Usanmaz, S. E. and Akarsu, E. S. (2000) Effects of chronic ethanol administration on serotonin metabolism in the various regions of the rat brain. Neurochemical Research 25, 257-262.
90. Uzbay, T. I., Kayir, H. and Ceyhan, M. (2007). Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: Possible role of adenosine A1 receptors. Neuropsychopharmacology 32, 412-416.
91. Uzbay, I. T., Erden, B. F., Tapanyigit, E. E. et al. (1997) Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sciences 61, 2197-2209.
92. Uzbay, I. T., Usanmaz, S., Tapanyidit, E. E. et al. (1998) Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: Association with behavioral signs. Drug and Alcohol Dependence 53, 39-47.
93. Uzbay, I. T., Saglam, E., Kayir, H. et al. (2004) Effects of fluoxetine on ethanol withdrawal syndrome in rats. Journal of Psychiatric Research 38, 445-450.
94. Uzbay, I. T., Kayir, H., Çelik, T. et al. (2006) Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30, 478-485.
95. Vaswani, M., Linda, F. K. and Ramesh, S. (2003) Role of serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 85-102.
96. Volz, H. P. (1997) Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30 (Suppl. 2), 72-76.
97. Waintraub, L., Septien, L. and Azoulay, P. (2000) Efficacy and safety of tianeptine in major depression: Evidence from a 3-month controlled clinical trial versus paroxetine. European Neuropsychopharmacology 10 (Suppl. 2), S51.
98. Wallis, C., Rezazadeh, M. and Lal, H. (1993) Role of serotonin in ethanol abuse. Drug Development Research 30, 178-188.
99. Wegener, G., Volke, V., Harvey, B. H. et al. (2003) Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Research 959 128-134.
100. Weissman, M. M. and Myers, J. K. (1980) Clinical depression in alcoholism. American Journal of Psychiatry 137, 372-373.
101. Wright, C. W., Gott, M., Grayson, B. et al. (2003) Correlation of hyperforin content of Hypericum perforatum (St. John's wort) extracts with their effects on alcohol drinking in C57BL/6J mice: A preliminary study. Journal of Psychopharmacology 17, 403-408.
102. Yaron, I., Shirazi, I., Judovich, R. et al. (1999) Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis and Rheumatism 42, 2561-2568.